Page last updated: 2024-12-11

sitosterol palmitate

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Cross-References

ID SourceID
PubMed CID9852570
SCHEMBL ID4739259
MeSH IDM0456668

Synonyms (25)

Synonym
beta-sitosteryl palmitate
16:0 sitosteryl ester
stigmast-5-en-3beta-yl hexadecanoate
LMST01020047
SCHEMBL4739259
sitosteryl palmitate
2308-85-2
sitosteryl palmitate, (+)-
sitosterol palmitate
stigmast-5-en-3-ol, 3-hexadecanoate, (3.beta.)-
LEB596GYDL ,
.beta.-rosasterol palmitate
stigmast-5-en-3.beta.-ol, palmitate
.beta.-sitosteryl palmitate
beta-rosasterol palmitate
stigmast-5-en-3beta-ol, palmitate
unii-leb596gydl
stigmast-5-en-3-ol, 3-hexadecanoate, (3beta)-
AKOS032962160
Q27896637
FS-9628
sitosterol palmitate;-sitosterol hexadecanoate; -sitosteryl palmitate
DTXSID601315058
[(3s,8s,9s,10r,13r,14s,17r)-17-[(2r,5r)-5-ethyl-6-methylheptan-2-yl]-10,13-dimethyl-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1h-cyclopenta[a]phenanthren-3-yl] hexadecanoate
caffeoyl pentose
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (5)

TimeframeStudies, This Drug (%)All Drugs %
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's3 (60.00)29.6817
2010's2 (40.00)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 12.63

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index12.63 (24.57)
Research Supply Index1.79 (2.92)
Research Growth Index4.42 (4.65)
Search Engine Demand Index0.00 (26.88)
Search Engine Supply Index0.00 (0.95)

This Compound (12.63)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other5 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]